GeoVax Labs, Inc. (NASDAQ:GOVX – Get Free Report) was the recipient of a significant increase in short interest during the month of September. As of September 30th, there was short interest totalling 301,200 shares, an increase of 17.2% from the September 15th total of 256,900 shares. Based on an average daily volume of 4,630,000 shares, the days-to-cover ratio is presently 0.1 days.
GeoVax Labs Stock Performance
Shares of GOVX traded down $0.01 during trading hours on Wednesday, hitting $2.10. The stock had a trading volume of 350,358 shares, compared to its average volume of 2,426,837. The firm has a 50-day moving average price of $3.49 and a 200 day moving average price of $2.54. GeoVax Labs has a fifty-two week low of $1.09 and a fifty-two week high of $11.18.
GeoVax Labs (NASDAQ:GOVX – Get Free Report) last posted its earnings results on Tuesday, August 6th. The company reported ($1.99) earnings per share (EPS) for the quarter, topping the consensus estimate of ($2.57) by $0.58. The firm had revenue of $0.30 million for the quarter. During the same quarter in the prior year, the firm posted ($3.30) earnings per share. Equities research analysts anticipate that GeoVax Labs will post -5.1 earnings per share for the current year.
Analyst Ratings Changes
Check Out Our Latest Analysis on GOVX
About GeoVax Labs
GeoVax Labs, Inc, a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers.
Read More
- Five stocks we like better than GeoVax Labs
- How to Read Stock Charts for Beginners
- Taiwan Semiconductor Stock: Buy Now or Wait for Earnings?
- 3 Healthcare Dividend Stocks to Buy
- Abbott’s Growth and Dividends Make It a Smart Portfolio Pick
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Citigroup Faces Growing Troubles: Could the Industry Be at Risk?
Receive News & Ratings for GeoVax Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeoVax Labs and related companies with MarketBeat.com's FREE daily email newsletter.